Anúncio
Anúncio
NXTC
NextCure, Inc. Common Stock
13.38
USDPatrocinado
-0.21
-1.51%
09 de jan., 15:56 UTC -5
Encerrado
Pós-Mercado
13.37
-0.02
-0.11%
Relatórios de Lucros NXTC
Rácio de surpresa positiva
NXTC separação 12 de 27 últimas estimativas.
44%
Próximo Relatório
Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.46
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-23.60%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-50.00%
NextCure, Inc. Common Stock earnings per share and revenue
On 05 de nov. de 2025, NXTC reported earnings of -3.22 USD per share (EPS) for Q3 25, beating the estimate of -4.06 USD, resulting in a 20.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -2.46 USD, with revenue projected to reach -- USD, implying an diminuir of -23.60% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were NextCure, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, NextCure, Inc. Common Stock reported EPS of -$3.22, beating estimates by 20.75%, and revenue of $0.00, 0% as expectations.
How did the market react to NextCure, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 1.97%, changed from $9.63 before the earnings release to $9.82 the day after.
When is NextCure, Inc. Common Stock expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for NextCure, Inc. Common Stock's next earnings report?
Based on 5
analistas, NextCure, Inc. Common Stock is expected to report EPS of -$2.46 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio